This study is led by Dr. Amy Hsu from the Bruyère Research Institute and Professor
Marc-André Langlois at the University of Ottawa, and involves many researchers from universities across Canada.
The goals of this study are to build a better understanding about how widespread
COVID-19 is in our most vulnerable and
high-risk populations, and to study the level and duration of protection of currently approved COVID-19 vaccines.